Physician profile
Steven D Johnson
NPI 1740272392
$1,491.75
in general payments reported to CMS, 2019-2025
21 companies · $17.36 in 2025
The $17.36 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,175 · 2020: $228 · 2022: $72.02 · 2025: $17.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $219.81 | 2019-2020 | |
| Gilead Sciences, INC. | $208.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $194.80 | 2019 | |
| Lantheus Medical Imaging, INC. | $137.63 | 2019 | |
| Hitachi Healthcare Americas Corp. | $125.89 | 2019-2020 | |
| Edwards Lifesciences Corporation | $111.08 | 2019 | |
| Lundbeck LLC | $88.10 | 2019 | |
| Pfizer INC. | $61.33 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $51.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.41 | 2019-2020 | |
| Boston Scientific Corporation | $44.64 | 2020 | |
| Acist Medical Systems, INC. | $39.94 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $35.16 | 2019-2020 | |
| Daiichi Sankyo INC. | $24.04 | 2019 | |
| Amarin Pharma, INC. | $18.61 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.19 | 2022 | |
| Cook Medical LLC | $17.36 | 2025 | Zilver Ptx |
| Arbor Pharmaceuticals, INC. | $14.34 | 2019 | |
| Chiesi USA, INC. | $12.22 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.09 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.